Skip to Main Content

Clinical Trials

The following trials are currently enrolling participants at Metro Health. For more information about any of them, email research@metrogr.org.

COVID-19

Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19
Condition: Severe or life threatening COVID-19 infection
Purpose: To grant access to potentially beneficial convalescent plasma to adult patients diagnosed with SARS-CoV-2 (COVID-19).
Investigators: Eric Feucht, MD; Jeffrey Fletcher, MD

Cancer

Metro Health – University of Michigan Health is a member of the Cancer Research Consortium of West Michigan (CRCWM). Visit www.crcwm.org for a listing of available clinical trials.

Neuroradiology

ASPIRE: Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery

Condition: Intracerebral hemorrhage and Non-Lobar Atrial Fibrillation
Purpose: To determine if apixiban is superior to aspirin for the prevention of the composite outcomes of a stroke in patients with recent intracerebral hemorrhage (ICH) and atrial fibrillation (AF).
Investigators: Augusto Elias, MD; Jeffrey Fletcher, MD

SATURN: Statins Use in Intracerebral Hemorrhage Patients

Condition: Intracerebral hemorrhage on statin therapy
Purpose: To determine whether continuation vs. discontinuation of statin drugs is the best strategy after a lobar intracerebral hemorrhage (ICH).
Investigators: Augusto Elias, MD; Jeffrey Fletcher, MD

Peripheral Artery Disease

LUTONIX BTK
Condition: Peripheral Artery Disease (PAD)
Goal: To learn more about the benefits of using the Lutonix Drug-Coated Balloon catheter (formerly, Moxy Drug-Coated Balloon catheter) and to gather more data to show it’s safe when treating people with narrowed leg blood vessels.
Principal Investigator: Larry Diaz, MD

PRIME Registry
Condition: Peripheral Artery Disease (PAD)
Purpose: Evaluate immediate and long-term outcomes of endovascular revascularization in patients with Critical Limb Ischemia (CLI) and advanced PAD.
Principal Investigator: Larry Diaz, MD

Heart Disease

APPRAISE
Assessment of Primary Prevention Patients Receiving An ICD – Systematic Evaluation of ATP
Condition: Fast or Irregular Heart Rhythms
Purpose: To understand the role of antitachycardia pacing (ATP) in patients receiving ICD therapy.
Principal Investigator: Matthew Sevensma, DO

BIOLIBRA Registry
Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy
Condition: Fast or Irregular Heart Rhythms
Purpose: To confirm the long-term safety and reliability of the BIOTRONIK ICD or CRT-D.
Principal Investigator: Matthew Sevensma, DO

CHEETAH
A Prospective, Multicenter Study to Evaluate the Safety and Performance of the CAT RX Aspiration Catheter in Patients with a High Thrombus Burden Acute Coronary Vessel Occlusion
Condition: Heart attack
Purpose: To confirm the safety and performance of the CAT RX Aspiration Catheter in patients with a clot in the heart resulting in a heart attack.
Principal investigator: Larry Diaz, MD

HERITAGE
Multi-center, cross-sectional, epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease
Condition: Heart Attack, Stroke, or Peripheral Vascular Disease
Purpose: To determine if patients have an elevated lipoprotein(a) lab value.
Principal investigator: Rony Gorges, MD

Pulmonology

CHRONICLE
A Longitudinal Prospective Observational Study of the Characteristics, Treatment Patterns and Health Outcomes of Individuals with Severe Asthma in the United States
Condition: Severe Asthma
Purpose: To collect information on patient characteristics, treatment patterns, and health outcomes in patients with severe asthma.
Investigator: Gregory Neagos, MD

KNOCOUT PE
Retrospective and Prospective International EkoSonic Registry of the Treatment and Clinical Outcomes of Patients With Pulmonary Embolism
Condition: Pulmonary Embolism
Purpose: To determine the treatment regimens used globally for EkoSonic therapy.
Investigator: Larry Diaz, MD

Sleep

remede System Therapy Registry (reST Registry)
Condition: Central Sleep Apnea
The purpose of this registry is to collect safety and effectiveness data in participants with central sleep apnea implanted with the remede System.
Investigator: Matthew Sevensma, DO